# ONCY (Oncolytics Biotech Inc.) - SEC EDGAR Financial Statements

> Oncolytics Biotech Inc. reported $5.83M in total assets and a net loss of $37.28M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/ONCY
- Markdown: https://convexityos.com/fundamentals/ONCY.md
- SEC CIK: 0001129928
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:00 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001129928&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$37.89M | Operating profit |
| Net Income | FY 2025 | -$37.28M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$0.29 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$28.79M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $2.43M | Total debt: $410K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 |
| --- | --- | --- |
| Research & Development | $13.31M | $15.44M |
| Total Operating Expenses | $28.73M | $25.54M |
| **Operating Income** | -$28.73M | -$25.54M |
| **EBITDA** | -$28.66M | -$25.45M |
| Interest Income | $386K | $975K |
| Income Before Tax | -$28.68M | -$22.70M |
| Income Tax Expense | $79K | $95K |
| **Net Income** | -$28.76M | -$22.79M |
| Basic EPS | -$0.30 | -$0.30 |
| **Diluted EPS** | -$0.30 | -$0.30 |
| Basic Shares Outstanding | 95.9M | 76.5M |
| Diluted Shares Outstanding | 95.9M | 76.5M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $5.15M | $4.26M | $4.55M | $3.52M | $5.08M | $1.92M | $2.80M |
| Total Operating Expenses | $9.74M | $9.38M | $9.28M | $9.49M | $9.56M | $4.65M | $5.02M |
| **Operating Income** | -$9.74M | -$9.38M | -$9.28M | -$9.49M | -$9.56M | -$4.65M | -$5.02M |
| **EBITDA** | -$9.72M | -$9.36M | -$9.27M | -$9.47M | -$9.55M | -$4.63M | -$5.00M |
| Interest Income | $19K | $37K | $44K | $74K | $95K | $100K | $117K |
| Income Before Tax | -$9.72M | -$9.34M | -- | -- | -$10.06M | -$5.22M | -- |
| Income Tax Expense | -$13K | $101K | -- | -- | -$181K | $61K | -- |
| **Net Income** | -$9.71M | -$9.44M | -$9.24M | -$8.89M | -$9.88M | -$5.28M | -$4.71M |
| Basic EPS | -$0.08 | -$0.08 | -$0.08 | -- | -$0.10 | -$0.06 | -$0.06 |
| **Diluted EPS** | -$0.08 | -$0.08 | -$0.08 | -- | -$0.10 | -$0.06 | -$0.06 |
| Basic Shares Outstanding | 127.9M | 119.7M | 112.3M | -- | 101.3M | 91.0M | 84.6M |
| Diluted Shares Outstanding | 127.9M | 119.7M | 112.3M | -- | 101.3M | 91.0M | 84.6M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 |
| --- | --- | --- |
| Cash & Cash Equivalents | $5.20M | $11.08M |
| **Cash & Short-Term Investments** | $5.20M | $11.08M |
| **Total Current Assets** | $6.84M | $12.44M |
| Property, Plant & Equipment, Net | $228K | $286K |
| **Total Non-Current Assets** | $738K | $985K |
| **Total Assets** | $7.58M | $13.42M |
| Accounts Payable | $3.50M | $756K |
| Other Current Liabilities | $0 | $1.12M |
| **Total Current Liabilities** | $6.10M | $4.88M |
| Deferred Revenue (Non-Current) | $4.91M | $4.68M |
| **Total Non-Current Liabilities** | $5.28M | $5.24M |
| **Total Liabilities** | $11.38M | $10.12M |
| **Total Debt (incl. Leases)** | $563K | $761K |
| Common Stock | $0 | $0 |
| Retained Earnings | -$429.5M | -$400.7M |
| Accumulated Other Comp. Income | $6.22M | $6.36M |
| **Total Stockholders' Equity** | -$3.80M | $3.30M |
| Total Equity | -$3.80M | $3.30M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $2.43M | $4.12M | $5.49M | $5.20M | $11.08M |
| **Cash & Short-Term Investments** | $2.43M | $4.12M | $5.49M | $5.20M | $11.08M |
| **Total Current Assets** | $5.27M | $7.07M | $7.49M | $6.84M | $12.44M |
| Property, Plant & Equipment, Net | $193K | $202K | $218K | $228K | $286K |
| **Total Non-Current Assets** | $558K | $602K | $674K | $738K | $985K |
| **Total Assets** | $5.83M | $7.67M | $8.16M | $7.58M | $13.42M |
| Accounts Payable | $3.21M | $3.40M | $2.68M | $3.50M | $756K |
| Other Current Liabilities | -- | -- | -- | $0 | $1.12M |
| **Total Current Liabilities** | $5.92M | $5.22M | $5.42M | $6.10M | $4.88M |
| Deferred Revenue (Non-Current) | $4.91M | $4.91M | $4.91M | $4.91M | $4.68M |
| **Total Non-Current Liabilities** | $7.42M | $8.61M | $7.87M | $5.28M | $5.24M |
| **Total Liabilities** | $13.34M | $13.84M | $13.29M | $11.38M | $10.12M |
| **Total Debt (incl. Leases)** | $410K | $448K | $508K | $563K | $761K |
| Common Stock | $0 | $0 | $0 | $0 | $0 |
| Retained Earnings | -$457.9M | -$448.2M | -$438.7M | -$429.5M | -$400.7M |
| Accumulated Other Comp. Income | $6.22M | $6.22M | $6.22M | $6.22M | $6.36M |
| **Total Stockholders' Equity** | -$7.50M | -$6.17M | -$5.13M | -$3.80M | $3.30M |
| Total Equity | -$7.50M | -$6.17M | -$5.13M | -$3.80M | $3.30M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 |
| --- | --- | --- |
| Net Income | -$28.76M | -$22.79M |
| Depreciation & Amortization | $70K | $87K |
| Stock-Based Compensation | $3.10M | $1.98M |
| Change in Payables | $2.93M | $4.0K |
| **Operating Cash Flow** | -$20.11M | -$19.88M |
| Capital Expenditure | -$6.0K | -$174K |
| **Free Cash Flow** | -$20.12M | -$20.06M |
| **Investing Cash Flow** | -$6.0K | -$174K |
| **Financing Cash Flow** | $14.12M | $5.03M |
| **Net Change in Cash** | -$5.88M | -$15.32M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$9.71M | -$9.44M | -$9.24M | -$8.89M | -$9.88M | -$5.28M | -$4.71M |
| Depreciation & Amortization | $17K | $15K | $16K | $16K | $17K | $18K | $19K |
| Stock-Based Compensation | $1.29M | $1.79M | $2.30M | $985K | $912K | $362K | $845K |
| Change in Payables | -$190K | $730K | -$813K | $1.22M | $1.36M | $242K | $112K |
| **Operating Cash Flow** | -$6.92M | -$8.14M | -$7.29M | -$6.43M | -$4.84M | -$4.11M | -$4.73M |
| Capital Expenditure | -$7.0K | $0 | -$6.0K | -$1.0K | -$4.0K | $0 | -$1.0K |
| **Free Cash Flow** | -$6.92M | -$8.14M | -$7.30M | -$6.43M | -$4.85M | -$4.11M | -$4.73M |
| **Investing Cash Flow** | -$7.0K | $0 | -$6.0K | -$1.0K | -$4.0K | $0 | -$1.0K |
| Common Stock Issued | -- | -- | $7.61M | -- | -- | -- | $4.18M |
| **Financing Cash Flow** | $5.24M | $6.77M | $7.61M | $2.75M | $3.09M | $4.09M | $4.18M |
| **Net Change in Cash** | -$1.69M | -$1.38M | $291K | -$3.67M | -$1.85M | $76K | -$434K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 |
| --- | --- | --- |
| Return on Equity (ROE) | -- | -691.1% |
| Return on Assets (ROA) | -379.3% | -169.8% |
| Current Ratio | 1.12x | 2.55x |
| Quick Ratio | 0.85x | 2.27x |
| Debt to Equity | -- | 0.23x |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Assets (ROA) | -639.3% | -488.3% | -407.9% | -379.3% | -- | -- | -- |
| Current Ratio | 0.89x | 1.35x | 1.38x | 1.12x | -- | -- | -- |
| Quick Ratio | 0.41x | 0.79x | 1.01x | 0.85x | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
